239 related articles for article (PubMed ID: 11293453)
1. Development of insulin-dependent diabetes mellitus in a patient with chronic hepatitis C during therapy with interferon-alpha.
Eibl N; Gschwantler M; Ferenci P; Eibl MM; Weiss W; Schernthaner G
Eur J Gastroenterol Hepatol; 2001 Mar; 13(3):295-8. PubMed ID: 11293453
[TBL] [Abstract][Full Text] [Related]
2. Trajectories of anti-islet autoantibodies before development of type 1 diabetes in interferon-treated hepatitis C patients. Case reports and a literature review.
Nakamura K; Kawasaki E; Abiru N; Jo O; Fukushima K; Satoh T; Kuriya G; Kobayashi M; Kuwahara H; Yamasaki H; Ide T; Eguchi K
Endocr J; 2010; 57(11):947-51. PubMed ID: 20805634
[TBL] [Abstract][Full Text] [Related]
3. Onset of type 1 diabetes mellitus during peginterferon alpha-2b plus ribavirin treatment for chronic hepatitis C.
Cozzolongo R; Betterle C; Fabris P; Paola Albergoni M; Lanzilotta E; Manghisi OG
Eur J Gastroenterol Hepatol; 2006 Jun; 18(6):689-92. PubMed ID: 16702861
[TBL] [Abstract][Full Text] [Related]
4. Type 1 diabetes mellitus provoked by peginterferon alpha-2b plus ribavirin treatment for chronic hepatitis C.
Tanaka J; Sugimoto K; Shiraki K; Beppu T; Yoneda K; Fuke H; Yamamoto N; Ito K; Takei Y
Intern Med; 2008; 47(8):747-9. PubMed ID: 18421192
[TBL] [Abstract][Full Text] [Related]
5. A case of chronic hepatitis C developing insulin-dependent diabetes mellitus associated with various autoantibodies during interferon therapy.
Uto H; Matsuoka H; Murata M; Okamoto T; Miyata Y; Hori T; Ido A; Hirono S; Hayashi K; Tsubouchi H
Diabetes Res Clin Pract; 2000 Aug; 49(2-3):101-6. PubMed ID: 10963820
[TBL] [Abstract][Full Text] [Related]
6. Fulminant autoimmune Type 1 diabetes during interferon-alpha therapy: a case of Th1-mediated disease?
Bosi E; Minelli R; Bazzigaluppi E; Salvi M
Diabet Med; 2001 Apr; 18(4):329-32. PubMed ID: 11437866
[TBL] [Abstract][Full Text] [Related]
7. Autoimmune manifestations during interferon therapy in patients with chronic hepatitis C: the hepatologist's view.
Pellicano R; Smedile A; Peyre S; Astegiano M; Saracco G; Bonardi R; Rizzetto M
Minerva Gastroenterol Dietol; 2005 Mar; 51(1):55-61. PubMed ID: 15756146
[TBL] [Abstract][Full Text] [Related]
8. Autoimmunity against pancreatic islets and other tissues before and after interferon-alpha therapy in patients with hepatitis C virus chronic infection.
Betterle C; Fabris P; Zanchetta R; Pedini B; Tositti G; Bosi E; de Lalla F
Diabetes Care; 2000 Aug; 23(8):1177-81. PubMed ID: 10937518
[TBL] [Abstract][Full Text] [Related]
9. Insulin-dependent diabetes mellitus during alpha-interferon therapy for chronic viral hepatitis.
Fabris P; Betterle C; Greggio NA; Zanchetta R; Bosi E; Biasin MR; de Lalla F
J Hepatol; 1998 Mar; 28(3):514-7. PubMed ID: 9551692
[TBL] [Abstract][Full Text] [Related]
10. [Type 1 diabetes developing during alpha-interferon therapy: report of two cases].
Vinagre I; Rigla M; Torras X; Enríquez J; Corcoy R
Endocrinol Nutr; 2010 Oct; 57(8):393-5. PubMed ID: 20462813
[No Abstract] [Full Text] [Related]
11. Thyroid function and changes in ultrasound morphology during antiviral therapy with pegylated interferon and ribavirin in patients with chronic hepatitis C.
Friedrich-Rust M; Theobald J; Zeuzem S; Bojunga J
J Viral Hepat; 2009 Mar; 16(3):168-77. PubMed ID: 19175874
[TBL] [Abstract][Full Text] [Related]
12. Late development of diabetes mellitus after interferon-alfa and ribavirin therapy for chronic hepatitis C: a case report.
Radhakrishnan S; Upadhyay A; Mohan N; Dhar A; Walia HK; Zubaidi G
Med Princ Pract; 2005; 14(4):281-3. PubMed ID: 15961942
[TBL] [Abstract][Full Text] [Related]
13. Type 1 diabetes mellitus with dual autoimmune mechanism related to pegylated interferon and ribavirin treatment for chronic HCV hepatitis.
Popescu C; Popescu GA; Arama V
J Gastrointestin Liver Dis; 2013 Mar; 22(1):101-4. PubMed ID: 23539399
[TBL] [Abstract][Full Text] [Related]
14. [Pegylated-interferon-induced diabetes mellitus type 1 in two patients with chronic hepatitis C].
Primo Vera J
Gastroenterol Hepatol; 2004 Feb; 27(2):69. PubMed ID: 14733882
[No Abstract] [Full Text] [Related]
15. [Autoantibodies against islet cell antigens and type 1 diabetes after treatment with interferon-alpha].
Schories M; Peters T; Rasenack J; Reincke M
Dtsch Med Wochenschr; 2004 May; 129(20):1120-4. PubMed ID: 15143453
[TBL] [Abstract][Full Text] [Related]
16. Resolution of diabetes in type 2 diabetic patient treated with IFN-alpha and ribavirin for hepatitis C.
Tahrani A; Bowler L; Singh P; Coates P
Eur J Gastroenterol Hepatol; 2006 Mar; 18(3):291-3. PubMed ID: 16462544
[TBL] [Abstract][Full Text] [Related]
17. A case of type 1 diabetes onset and recurrence of Graves' disease during pegylated interferon-α plus ribavirin treatment for chronic hepatitis C.
Fujioka T; Honda M; Yoshizaki T; Ogawa M; Matsuno H; Shimokawa K; Koyama K
Intern Med; 2010; 49(18):1987-90. PubMed ID: 20847504
[TBL] [Abstract][Full Text] [Related]
18. Distinct clinical courses in type 1 diabetes mellitus induced by peg-interferon-alpha treatment for chronic hepatitis C.
Yamazaki M; Sato A; Takeda T; Komatsu M
Intern Med; 2010; 49(5):403-7. PubMed ID: 20190473
[TBL] [Abstract][Full Text] [Related]
19. Autoantibodies and autoimmune disease during treatment of children with chronic hepatitis C.
Molleston JP; Mellman W; Narkewicz MR; Balistreri WF; Gonzalez-Peralta RP; Jonas MM; Lobritto SJ; Mohan P; Murray KF; Njoku D; Rosenthal P; Barton BA; Talor MV; Cheng I; Schwarz KB; Haber BA;
J Pediatr Gastroenterol Nutr; 2013 Mar; 56(3):304-10. PubMed ID: 23439301
[TBL] [Abstract][Full Text] [Related]
20. The influence of interferon alpha on the induction of autoimmune thyroiditis in patients treated for chronic viral hepatitis type C.
Krupińska J; Wawrzynowicz-Syczewska M; Urbanowicz W; Pobłocki J; Syrenicz A
Endokrynol Pol; 2011; 62(6):517-22. PubMed ID: 22144218
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
